SCHEMBL6137634

SCHEMBL6137634

O=C1Nc2ccccc2C2CCCC12F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.48
NOS1 P29475 3/20 0.48
NOS2 P35228 3/20 0.48
APOBEC3A P31941 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37
ALDH1A1 P00352 2/20 0.37
IDO1 P14902 2/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
BACE1 P56817 1/20 0.33
HTR5A P47898 1/20 0.32
DDB1 Q16531 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137338 0.81 NOS3 (0.48) NOS3NOS1NOS2ALDH1A1HTR5A
SCHEMBL6137467 0.80 POLB (0.43) NOS3NOS1NOS2HSD17B10MEN1
SCHEMBL6137746 0.80 NOS3 (0.55) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL6137774 0.76 NOS3 (0.39) NOS3NOS1NOS2IDO1POLB
SCHEMBL7171088 0.76 HTT (0.37) NOS3NOS1NOS2HTTHSD17B10
SCHEMBL6137525 0.74 NOS3 (0.41) NOS3NOS1NOS2POLB
SCHEMBL6137625 0.73 NOS3 (0.40) NOS3NOS1NOS2
SCHEMBL2766002 0.67 ALDH1A1 (0.46) ALDH1A1IDO1MEN1POLBKMT2A
SCHEMBL6137311 0.65 NOS1 (1.00) NOS3NOS1NOS2
SCHEMBL6137325 0.63 NOS3 (0.52) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed